ASPEN NEUROSCIENCE
Aspen Neuroscience is a development stage and private biotechnology company that uses innovative genomic approaches combined with stem cell biology to deliver patient-specific, restorative cell therapies that modify the course of Parkinson's disease. It is developing induced-pluripotent stem cells (iPSCs) to address diseases with high unmet medical needs, beginning with autologous neuron replacement for both sporadic and genetic forms of Parkinson's disease (PD) and extending across the brain and affected organs.
ASPEN NEUROSCIENCE
Industry:
Biotechnology Medical Pharmaceutical Therapeutics
Founded:
2018-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.aspenneuroscience.com
Total Employee:
51+
Status:
Active
Contact:
+1 858 263 1222
Total Funding:
272 M USD
Technology used in webpage:
Domain Not Resolving Euro CrUX Dataset CrUX Top 10m
Similar Organizations
Artyc
Artyc offers cold shipping of biotech, pharmaceutical, and medical goods.
Bon Vivant
A French biotechnology company that uses precision fermentation to produce real dairy products, accessible to everyone.
C16 Biosciences
C16 Biosciences produces clean, safe alternatives to palm oil.
Enveda Biosciences
Enveda Biosciences is a biotechnology company building new medicines from plants.
Immunome
Immunome is a biotechnology company that specializes in immunotherapy, biotechnology, and antigen discovery.
Splice Bio
Splice Bio is a biotech company based on intein technologies developed in the Muir Lab at Princeton University.
Translate Bio
Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases.
Terremoto Biosciences
Terremoto Biosciences is a biotechnology company leveraging the power of lysine-based covalency to develop optimized medicines.
Current Advisors List
Board_member
2018-04-01
Board_member
Board_member
Board_member
2022-05-01
Board_member
Current Employees Featured
Jeanne Loring Co-Founder & Chief Scientific Officer @ Aspen Neuroscience
Co-Founder & Chief Scientific Officer
Xiaokui Zhang Chief Scientific Officer @ Aspen Neuroscience
Chief Scientific Officer
2021-08-01
Ana Sousa Chief Regulatory Officer @ Aspen Neuroscience
Chief Regulatory Officer
2024-01-01
Afif Khoury Investor @ Aspen Neuroscience
Investor
2018-10-01
Kameel Farag CFO @ Aspen Neuroscience
CFO
2021-07-01
Lisa Johnson-Pratt Senior Vice President, Therapeutic Program Lead @ Aspen Neuroscience
Senior Vice President, Therapeutic Program Lead
2024-01-01
Andres Bratt-Leal SVP, Research and Development @ Aspen Neuroscience
SVP, Research and Development
2021-01-01
Kim Raineri Chief Technology Officer @ Aspen Neuroscience
Chief Technology Officer
2022-07-01
Ana Sousa SVP Global Regulatory Affairs, Quality & Product Strategy @ Aspen Neuroscience
SVP Global Regulatory Affairs, Quality & Product Strategy
2021-04-01
Founder
Investors List
California Institute for Regenerative Medicine
California Institute for Regenerative Medicine investment in Grant - Aspen Neuroscience
Silicon Valley Bank
Silicon Valley Bank investment in Debt Financing - Aspen Neuroscience
Google Ventures
Google Ventures investment in Series B - Aspen Neuroscience
Frazier Life Sciences
Frazier Life Sciences investment in Series B - Aspen Neuroscience
Gaingels
Gaingels investment in Series B - Aspen Neuroscience
Medical Excellence Capital
Medical Excellence Capital investment in Series B - Aspen Neuroscience
OrbiMed
OrbiMed investment in Series B - Aspen Neuroscience
Newton Investment Management
Newton Investment Management investment in Series B - Aspen Neuroscience
Bioverge
Bioverge investment in Series B - Aspen Neuroscience
LYFE Capital
LYFE Capital investment in Series B - Aspen Neuroscience
Key Employee Changes
Official Site Inspections
http://www.aspenneuroscience.com
- Host name: 141.193.213.21
- IP address: 141.193.213.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Aspen Neuroscience"
About Us - Aspen
The company was founded in 2018 by a group of research scientists from Dr. Jeanne Loring’s lab at The Scripps Research Institute, and a group of patient advocates from Summit for Stem …See details»
Aspen Neuroscience - Crunchbase Company Profile
Aspen Neuroscience is a development stage and private biotechnology company that uses innovative genomic approaches combined with stem cell biology to …See details»
Aspen Neuroscience, Inc. | LinkedIn
Aspenneuroscience.com 413 19 Comments Like Comment Share Aspen Neuroscience, Inc. 9,094 followers 2mo Report this post Aspen is advancing our plans for automating production of ANPD001, including ...See details»
Aspen Neuroscience - PitchBook
Www.aspenneuroscience.com. Formerly Known As. Aspen Biosciences. Ownership Status. Privately Held (backing) Financing Status. Venture Capital …See details»
Aspen Neuroscience - Overview, News & Similar companies
Jan 16, 2024 Aspen Neuroscience contact info: Phone number: (858) 263-1222 Website: www.aspenneuroscience.com What does Aspen Neuroscience do? Headquartered in San …See details»
Aspen Neuroscience
Aspen Neuroscience leverages stem cell biology and genomics for Parkinson disease. We are the leading company providing a personalized cell therapy with the aim to safely turn the clock …See details»
Aspen Neuroscience, Inc. - Drug pipelines, Patents, Clinical trials ...
Mar 7, 2025 Explore Aspen Neuroscience, Inc. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 39 news, and 2 literature, Disease Domain:Nervous …See details»
Aspen Neuroscience - Craft
Aspen Neuroscience has 5 employees at their 1 location and $76.5 m in total funding,. See insights on Aspen Neuroscience including office locations, competitors, revenue, financials, …See details»
Aspen Neuroscience - Work in biotech
Aspen Neuroscience is combining stem cell biology with genomics to create therapies to treat patients with neurodegenerative diseases. Parkinson’s Disease is the second most common …See details»
aspenneuroscience.org
Aspenneuroscience.orgSee details»
Aspen Neuroscience Announces $147.5 Million Series B Financing, …
May 9, 2022 GV, LYFE Capital and Revelation Partners co-led the investment round with participation from additional new investors Newton Investment Management, Singapore-based …See details»
Aspen Neuroscience Announces Completion of First and Second …
Jan 13, 2025 Aspen Neuroscience, Inc. has successfully completed dose escalation and the first two cohorts of patients in the ASPIRO study, an ANPD001 Phase 1/2a clinical trial in …See details»
Aspen Neuroscience Announces Completion of First and Second …
Jan 13, 2025 The company has developed a best-in-class platform to create and optimize pluripotent-derived cell therapies, which includes in-house bioinformatics, manufacturing and …See details»
Our Advisors - Aspen - Aspen Neuroscience
Co-Founder, Aspen Neuroscience. Dr. Jeanne Loring is a world-renowned stem cell scientist and co-founder of Aspen Neuroscience. Dr. Loring’s work provided the expertise and intellectual …See details»
Working at Aspen Neuroscience - Glassdoor
Pros. Communication across multiple levels in a complex biomedical industrial automation pipeline is working remarkably well. Teams have their tasks, management is communicating …See details»
Aspen Neuroscience Launches First Patient Screening Study for …
SAN DIEGO, April 11, 2022 /PRNewswire/ -- Aspen Neuroscience, Inc., a private biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies, including the …See details»
Series B Financing Announced - Aspen
For more information and important updates, please visit aspenneuroscience.com. Aspen Neuroscience does not make determination on patient eligibility for clinical trials and all trial …See details»
Aspen Neuroscience Advances the Automated Production of …
Jan 8, 2025 Company is scaling out production of ANPD001 investigational cell therapy. SAN DIEGO, Jan. 8, 2025 /PRNewswire/ -- Aspen Neuroscience, Inc. has advanced its plans for …See details»
Research highlights roles of nature and nurture in brain organization
5 days ago The findings, published March 17 in Nature Human Behaviour, reveal that while key aspects of brain organization are present from birth, there’s also significant capacity for …See details»
Aspen Neuroscience Advances the Automated Production of …
Jan 8, 2025 Company is scaling out production of ANPD001 investigational cell therapy. SAN DIEGO, Jan. 8, 2025 /PRNewswire/ — Aspen Neuroscience, Inc. has advanced its plans for …See details»